US Bancorp
CNMD icon

US Bancorp’s CONMED CNMD Stock Holding History

US Bancorp’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Sell
13,606
-229
-2% -$8.24K ﹤0.01% 1652
2026
Q1 		$489K Sell
13,835
-2,941
-18% -$120K ﹤0.01% 1522
2025
Q4 		$681K Buy
16,776
+4,718
+39% +$205K ﹤0.01% 1366
2025
Q3 		$567K Buy
12,058
+1,731
+17% +$89.7K ﹤0.01% 1428
2025
Q2 		$538K Buy
10,327
+1,621
+19% +$89K ﹤0.01% 1462
2025
Q1 		$526K Buy
8,706
+4,557
+110% +$294K ﹤0.01% 1456
2024
Q4 		$284K Buy
4,149
+567
+16% +$39.5K ﹤0.01% 1826
2024
Q3 		$258K Buy
3,582
+2,774
+343% +$196K ﹤0.01% 1895
2024
Q2 		$56K Buy
808
+191
+31% +$13.9K ﹤0.01% 2606
2024
Q1 		$49.4K Sell
617
-4,778
-89% -$426K ﹤0.01% 2707
2023
Q4 		$591K Buy
5,395
+4,429
+458% +$458K ﹤0.01% 1398
2023
Q3 		$97.4K Sell
966
-7,314
-88% -$840K ﹤0.01% 2164
2023
Q2 		$1.13M Sell
8,280
-677
-8% -$82.6K ﹤0.01% 1005
2023
Q1 		$930K Sell
8,957
-2,574
-22% -$249K ﹤0.01% 1110
2022
Q4 		$1.02M Sell
11,531
-4,042
-26% -$335K ﹤0.01% 1056
2022
Q3 		$1.25M Buy
15,573
+13
+0.1% +$1.23K ﹤0.01% 963
2022
Q2 		$1.49M Buy
15,560
+973
+7% +$117K ﹤0.01% 933
2022
Q1 		$2.17M Buy
14,587
+1,144
+9% +$160K ﹤0.01% 855
2021
Q4 		$1.91M Buy
13,443
+2,580
+24% +$365K ﹤0.01% 935
2021
Q3 		$1.42M Buy
10,863
+1,320
+14% +$173K ﹤0.01% 1017
2021
Q2 		$1.31M Sell
9,543
-2,706
-22% -$370K ﹤0.01% 1063
2021
Q1 		$1.6M Buy
12,249
+218
+2% +$26.2K ﹤0.01% 938
2020
Q4 		$1.35M Buy
12,031
+4,147
+53% +$393K ﹤0.01% 975
2020
Q3 		$620K Buy
7,884
+5,508
+232% +$449K ﹤0.01% 1217
2020
Q2 		$171K Buy
2,376
+304
+15% +$21.1K ﹤0.01% 1841
2020
Q1 		$119K Buy
2,072
+682
+49% +$62.9K ﹤0.01% 1938
2019
Q4 		$155K Buy
1,390
+73
+6% +$7.78K ﹤0.01% 1966
2019
Q3 		$126K Buy
1,317
+181
+16% +$17K ﹤0.01% 2036
2019
Q2 		$97K Sell
1,136
-188
-14% -$15.5K ﹤0.01% 2226
2019
Q1 		$110K Buy
1,324
+430
+48% +$31.2K ﹤0.01% 2139
2018
Q4 		$57K Sell
894
-15
-2% -$1.03K ﹤0.01% 2383
2018
Q3 		$72K Buy
909
+121
+15% +$9.36K ﹤0.01% 2382
2018
Q2 		$58K Buy
788
+217
+38% +$14.8K ﹤0.01% 2501
2018
Q1 		$36K Hold
571
– – ﹤0.01% 2749
2017
Q4 		$29K Hold
571
– – ﹤0.01% 2802
2017
Q3 		$30K Hold
571
– – ﹤0.01% 2762
2017
Q2 		$29K Hold
571
– – ﹤0.01% 2761
2017
Q1 		$25K Hold
571
– – ﹤0.01% 2769
2016
Q4 		$25K Hold
571
– – ﹤0.01% 2743
2016
Q3 		$23K Sell
571
-54
-9% -$2.29K ﹤0.01% 2759
2016
Q2 		$30K Sell
625
-9
-1% -$381 ﹤0.01% 2628
2016
Q1 		$27K Buy
634
+228
+56% +$8.95K ﹤0.01% 2653
2015
Q4 		$18K Buy
406
+5
+1% +$217 ﹤0.01% 2862
2015
Q3 		$19K Buy
+401
New +$22K ﹤0.01% 2874
2013
Q3 		– Sell
-62
Closed -$2K – 3278
2013
Q2 		$2K Buy
+62
New +$2.01K ﹤0.01% 3135

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

US Bancorp's CNMD Position: Q2 2026 in Review

US Bancorp reduced its CONMED (CNMD) stake by 1.7% in Q2 2026, selling an estimated $8.24K and leaving 13,606 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #1652.

US Bancorp first reported a position in CNMD in Q2 2013 and has held it in 45 quarters since. The position peaked at $2.17M in Q1 2022. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • US Bancorp held 13,606 shares of CONMED worth $445K as of Q2 2026.
  • US Bancorp sold 229 CONMED shares in Q2 2026, an estimated $8.24K.
  • CONMED made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1652 holding.
  • US Bancorp first reported a position in CONMED in Q2 2013 and has held it in 45 quarters since.
  • US Bancorp's CONMED position peaked at $2.17M in Q1 2022.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.